Gene Query: PSMB4

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 438.94
An RNA-centric dissection of host complexes controlling flavivirus infection 40.69
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 40.69
NRDE2 negatively regulates nuclear exosome functions 31.47
EWSR1 influences alternative splicing through direct and indirect mechanisms 28.52
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 27.37
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 25.04
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 24.42
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 23.08
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 21.71
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 20.28
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 20.28
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 20.13
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 19.48
Mitochondrial dsRNA triggers antiviral signalling in humans 18.8
RNA-sequencing of formalin fixed human primary melanoma tissue 18.78
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 18.46
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 18.06
Identification of transcription start sites for human A549 cell line using ReCappable-seq 18.02
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 16.86
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 15.94
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 15.94
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 15.86
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 15.85
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 15.75
The human blood-nerve barrier transcriptome 15.54
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 15.28
RNA-Seq analysis of breast cancer cells after shikonin treatment 14.91
3’ Uridylation Expands miRNA Target Repertoire 14.54
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 14.28
Role of XRN2 ribonucleolytic activity in RNA metabolism 14.1
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.79
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.76
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 13.67
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 13.53
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 13.45
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 13.27
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 13.1
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 12.99
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 12.95
Global transcriptome analysis of HAP1 cells 12.91
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 12.8
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 12.69
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 12.68
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.67
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 12.52
Comprehensive comparative analysis of 5’ end RNA sequencing methods 12.51
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.49
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.49
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 12.34
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 12.27
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 12.27
RNA sequencing of primary human platelets and in vitro cell lines 12.15
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 12.12
RNA m5C Methylation in breast cancer using MeRIP-Seq 12.08
Ribosomal footprinting of CN34-Parental and CN34-LM1a 11.96
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 11.94
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.85
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 11.78
Reassessment of Exosome Composition 11.63
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 11.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 11.29
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 11.1
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 11.09
RNA-Seq with and without RNase treatment in PCa cell lines 10.99
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 10.63
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.6
Global analysis of enhancer targets: Mosaic-seq 10.6
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.52
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 10.31
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.29
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 10.29
U1 snRNP telescripting regulates size-function stratified human genome 10.24
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 10.15
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 10.15
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 10.13
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 10.13
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 10.11
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 10.11
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.03
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.03
Short and Long RNA sequencing of human mature erythrocytes 10.02
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 9.86
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 9.86
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.74
HEK293 Heat-shock experiment 9.71
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.46
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.46
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.45
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.45
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.44
CROP-Seq in Primary Human T Cells 9.4
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 9.35
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 9.31
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.3
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 9.26
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.2
Sensing self and nonself circular RNAs 9.14
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 9.14
Genome-wide discovery of human splicing branchpoints [RNAse] 9.07
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.05
T47D RNA-seq and ChrRNA-seq data 9.04
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 9.04
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 9.0
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.95
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.9
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 8.86
A role for ZNF598 in post-transcriptional gene regulation 8.74
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.73
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.65
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 8.59
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 8.57
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 8.46
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 8.46
Transcription elongation regulates genome 3D structure 8.45
Differential expression of genes in AD169-infected MRC5. 8.45
miR941 overexpression experiment 8.39
LncRNA expression profiling of ischemic stroke patients 8.31
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 8.22
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.2
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.16
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.05
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 8.0
Effect of CHKA knockdown on C4-2 cell transcriptome 7.95
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 7.9
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 7.9
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 7.77
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.74
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.74
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.67
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.67
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.62
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.61
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 7.58
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.53
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.49
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.49
mRNA expression profile of Lymphocytes 7.46
Gene Expression Profiling of SPOP Knocked Down Cell 7.38
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 7.36
Tracking distinct RNA populations using efficient and reversible covalent chemistry 7.3
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.23
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.16
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.16
RNA-seq melanoma 7.15
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.12
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.07
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 7.07
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.07
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.06
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.04
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 6.99
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 6.96
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 6.86
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.8
Modeling Familial Cancer with iPSC Approaches 6.8
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 6.8
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.78
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 6.77
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 6.75
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 6.72
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 6.72
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.71
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.7
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.68
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.67
METTL3 and WTAP 6.67
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 6.67
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.62
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 6.59
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.56
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.56
Identification of Atrial Fibrillation associated genes and functional non-coding variants 6.55
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 6.53
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 6.53
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 6.48
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 6.44
Hepatocyte maturation 6.41
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.37
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.33
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.33
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.31
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.31
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.28
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 6.28
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.25
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.25
Exploring the RNA landscape of endothelial exosomes 6.24
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.21
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.19
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 6.18
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.17
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 6.14
Transcriptome landscape of HeLa response upon triamcinolone acetonide 6.12
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.12
The transcriptome and chromatin accessbility landscape of mammalian germline 6.11
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6.11
Transcriptomic analysis of the HOTAIR-regulated genes 6.08
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 6.07
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 6.07
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.03
LIN28A Over-expression RNAseq 5.94
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 5.92
Genome-wide discovery of human splicing branchpoints 5.89
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.88
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.85
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.84
Derivation and differentiation of haploid human embryonic stem cells 5.8
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.76
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 5.7
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 5.7
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.69
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.66
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.66
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 5.62
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.61
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.55
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.55
K562 polyA RNA-Seq 5.47
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 5.47
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 5.43
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 5.38
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.29
An optimization system for isolating and sequencing of single human colon cancer cells 5.29
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 5.28
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 5.28
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.26
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.13
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.13
mRNA expression in human DAOY cells 5.12
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.09
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.02
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.01
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 4.98
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.97
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.93
Profiling of escape kinetics of viruses subjected to RNAi 4.9
Biological effect of chronic mistranslation in mammalian cells 4.89
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.86
Transcriptome sequencing of K-562 cells 4.84
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.8
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 4.78
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.78
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 4.73
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.7
Activity-dependent transcriptional changes in human neurons 4.69
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 4.68
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.68
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.67
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.66
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.65
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.64
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.64
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 4.58
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.55
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.54
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.53
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.53
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.52
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 4.42
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.41
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.39
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 4.37
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.35
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.31
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.29
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.23
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.23
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.23
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.23
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.22
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 4.2
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 4.2
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.1
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.09
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.08
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.08
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 4.08
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.05
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.04
Gene expression changes caused by KRAS in MCF-10A 4.03
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.02
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.02
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 4.01
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.0
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.0
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.89
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.89
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.88
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 3.84
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 3.84
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.82
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.8
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.77
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.77
miR-93 Targets in Human Endothelial Cells 3.77
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.76
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.75
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.72
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.69
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.69
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.68
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.68
RNA editing in nascent RNA affects pre-mRNA splicing 3.67
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.64
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.58
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.58
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 3.55
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.53
High-resolution comparative analysis of great ape genomes 3.46
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.44
Differential gene expression profiles in imatinib-resistant cell lines 3.35
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.34
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.28
Transcriptome analysis upon C6orf203 silencing 3.24
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.17
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.16
Metastasis in triple-negative breast cancer 3.16
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.14
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.13
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.12
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.1
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.1
Global analyses of the effect of different cellular contexts on microRNA targeting 3.08
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.08
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.04
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.02
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.0
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.99
Identification of renal resident macrophages across species 2.98
Ebola virus (EBOV) infection of ARPE-19 cells 2.98
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.95
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.9
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.9
Transcriptome analysis of peripheral blood monocytes 2.86
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.85
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.84
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.83
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.83
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.83
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.8
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 2.77
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.77
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.75
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.66
Dilated cardiomyopathy vs Myocarditis 2.65
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.59
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.58
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.57
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.57
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 2.57
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.55
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.55
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 2.52
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 2.52
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.5
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.5
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.48
Determining mRNA half-lives on a transcriptome-wide scale 2.48
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.44
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.43
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.43
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.43
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.43
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.39
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.36
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.35
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.35
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.35
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.31
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.3
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.29
Patient-derived xenograft platform for metastatic melanoma 2.27
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.27
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.27
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.25
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.22
Transcriptome analysis of CNS leukemia 2.18
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.18
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.16
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.16
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.14
Transposon-based construction of strand-specific RNA-seq libraries 2.14
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.14
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.12
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.09
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.08
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.07
A single-cell transcriptome atlas of the human pancreas 2.05
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.03
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.98
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.96
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.92
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.9
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.88
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.88
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.87
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.79
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.74
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.64
Identification of renal resident macrophages across species [C1] 1.62
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.61
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.59
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.58
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.57
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.55
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.53
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.52
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.52
Regulatory network controlling tumor-promoting inflammation in human cancers 1.52
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.52
Transcriptome analysis of kidney organoids 1.5
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.47
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.43
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.43
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.42
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.4
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.38
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.38
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.36
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.36
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.31
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.3
Exogenous rescue of KLHL9 in SF210 cell line 1.29
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.29
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.29
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.29
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.28
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.28
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.27
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.26
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 1.25
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 1.25
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.24
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.2
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.2
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.2
Gene expression analysis of human adenomas. 1.2
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.14
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.07
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.06
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.05
siRNA-mediated knockdown 0.98
Metabolism as an early predictor of DPSCs aging 0.95
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.94
Induced DNA demethylation, genome instability and transcription 0.91
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.91
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.87
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.86
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 0.84
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.82
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.81
Gene expression profiling of KSHV-infected periodontal ligament cells 0.8
RNA-seq data 0.79
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.77
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.75
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.75
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.73
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.7
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.65
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.65
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.61
Measure transcript integrity using RNA-seq data 0.61
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.58
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.57
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.57
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.55
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.55
Myc activation coordinates gene transcription and protein translation responses 0.52
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.51
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.5
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.49
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.49
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.49
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.45
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.42
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.38
Iron response of HepG2 cells 0.35
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.32
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.32
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.32
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.29
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.27
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.27
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.24
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.22
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.21
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.21
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.08
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.08
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.06
Global transcriptome analysis of WT versus HEB-/- hESCs 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.04
O-glcnAc reprograms cellular energetics 0.02
Differential gene expression in Jagged1 treated human dental pulp cells. 0.01
Enhancer activation during EGF response 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation